Previous studies have suggested that many people who use proton pump inhibitors (PPIs) might not have a clinical indication for doing so, which is concerning because PPIs have been associated with chronic kidney disease and infection in some observational studies. Now, recent results published in The BMJ show that an intervention targeting overprescribing of PPIs might lead to quick, lasting reductions in their use.
